MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    “Best practice” guidelines for the collection and analysis of speech data in patients with Parkinson’s Disease (PD).

    E. Tripoliti, L. Ramig (Boulder Colorado, CO, USA)

    Objective: To discuss the literature for collection and analysis of speech data for patients with PD in order to create “best practice” guidelines. Background: Speech…
  • 2019 International Congress

    Neuroprotective actions of red propolis extract and formononetin in a rat model of Parkinson’s disease

    M. Gomes, S. Barroso, J. de Oliveira, D. Marques, A. Santos, J. Cardoso (Aracaju, Brazil)

    Objective: To evaluate the effects of the hydroalcoholic extract of red propolis (HERP) and one of its major compounds, formononetin (FN), against the motor symptoms…
  • 2019 International Congress

    Serotonergic function in De Novo Parkinson’s Disease

    HK. Park, JJ. Lee, YM. Park (Goyang, Republic of Korea)

    Objective: We aimed to investigate the central serotonergic function in de novo PD and change in serotonergic function with dopaminergic medications. Background: While dopaminergic dysfunction…
  • 2019 International Congress

    Oscillaotory activity in the globus pallidus internus in patients with Parkinson’s disease

    P. Zhuang, M. Hallett, D. Meng, Y. Zhang, J. Li, J. Li (Beijing, China)

    Objective: To quantify the characteristics of oscillatory neurons in the GPi in patients with PD. Background: Abnormal oscillatory activity has been predicted to play a…
  • 2019 International Congress

    Phenotypic segregation in kindred with a novel ANO3 variant

    V. Carvalho, F. Correia, J. Martins, J. Massano, T. Temudo (Matosinhos, Portugal)

    Objective: To describe the phenotypic and genotypic presentation of a kindred with a novel ANO3 mutation. Background: Mutations in ANO3 gene cause an autosomal dominant…
  • 2019 International Congress

    Role of pallidotomy in secondary dystonia in pediatric patients

    K. Garg, M. Singh, V. Goyal (New Delhi, India)

    Objective: Our study aimed to assess the role of pallidotomy in pediatric patients with secondary dystonia. Background: The response of primary dystonia to pallidal surgery…
  • 2019 International Congress

    Quality of life in isolated dystonia – a cross-sectional study

    J. Junker, B. Berman, D. Wahba, J. Hall, J. Perlmutter, J. Jankovic, I. Malaty, V. Brandt, S. Reich, A. Espay, N. Patel, E. Roze, M. Vidailhet, H. Jinnah, N. Brueggemann (Luebeck, Germany)

    Objective: To evaluate the relationship between health-related quality of life (HR-QoL) and both physical and psychiatric factors in a large, international, multi-centre cohort of isolated…
  • 2019 International Congress

    The effect of Kinesio Taping therapy on Cervical Dystonia

    J. Magalhães, A. Rosso, F. Rezende (Rio de Janeiro, Brazil)

    Objective: To test the efficacy of kinesio taping treatment   as an adjunct therapy to botulinum toxin in the treatment of cervical dystonia. Background: Botulinum toxin…
  • 2019 International Congress

    Differences in botulinum toxin long-term treated and non-treated cervical dystonia patients in somatosensory task-related functional imaging response.

    M. Nevrly, P. Hlustik, P. Hok, M. Kaiserova, P. Otruba, Z. Tudos, P. Kanovsky (Olomouc, Czech Republic)

    Objective: Aim of this study is to compare the response of sensorimotor networks to botulinum toxin (BoNT) therapy in naïve and repeatedly-treated CD patients. Background:…
  • 2019 International Congress

    Novel familial HPCA mutation associated with autosomal recessive dystonia: Strengthening the role of HPCA in hereditary movement disorders.

    S. Siegert, W. Schmidt, R. Bittner, S. Gobara, M. Freilinger (Vienna, Austria)

    Objective: The objective was to describe the genetic and clinical findings in a Turkish girl, her father and paternal uncle carrying a novel homozygous HPCA…
  • « Previous Page
  • 1
  • …
  • 144
  • 145
  • 146
  • 147
  • 148
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley